PTGS2 and cancer: COX-2 is released to the cancer microenvironment by type II macrophages, cancer−associated fibroblasts and tumor cells, and can suppress tumor cell apoptosis, enhance cell adhesion to promote tumor-induced angiogenesis and achieve an aggressive phenotype (114, 115).